These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 12466995

  • 1. [Barrett metaplasia: how dangerous is it really?].
    Stolte M, Vieth M.
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():5-8. PubMed ID: 12466995
    [No Abstract] [Full Text] [Related]

  • 2. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ, Spechler SJ.
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
    Ell C.
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
    [No Abstract] [Full Text] [Related]

  • 7. [Barrett esophagus and Barrett carcinoma].
    Kruyt PH, van Sandick JW, van Lanschot JJ, Offerhaus GJ, Tytgat GN, Obertop H.
    Ned Tijdschr Geneeskd; 1997 May 03; 141(18):869-73. PubMed ID: 9273450
    [Abstract] [Full Text] [Related]

  • 8. Adiposity and columnar-lined esophagus.
    Lenglinger J, Eisler M, Riegler FM.
    Am J Gastroenterol; 2008 May 03; 103(5):1316-7. PubMed ID: 18477363
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R.
    Cancer; 2007 Feb 15; 109(4):668-74. PubMed ID: 17211862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Barrett's esophageal adenocarcinoma].
    Nakamura T.
    Gan To Kagaku Ryoho; 2004 Mar 15; 31(3):322-6. PubMed ID: 15045933
    [Abstract] [Full Text] [Related]

  • 14. Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus.
    Tanaka K, Toyoda H, Kadowaki S, Hamada Y, Kosaka R, Yamanaka M, Imoto I.
    Endoscopy; 2007 Feb 15; 39 Suppl 1():E105-6. PubMed ID: 17440852
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M, Schubert B, Lang-Schwarz K, Stolte M.
    Endoscopy; 2006 Dec 15; 38(12):1201-5. PubMed ID: 17163319
    [Abstract] [Full Text] [Related]

  • 19. Magnified view of adenocarcinoma in short segment Barrett's esophagus treated by endoscopic mucosal resection.
    Yagi K, Nakamura A, Sekine A, Tamiya Y, Oyamatsu M.
    Gastrointest Endosc; 2002 Feb 15; 55(2):278-81. PubMed ID: 11818942
    [No Abstract] [Full Text] [Related]

  • 20. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I.
    Gastrointest Endosc; 2009 Sep 15; 70(3):417-21. PubMed ID: 19555948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.